Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)

Giuseppe De Luca*, Sander A. Damen, Cyril Camaro, Edouard Benit, Monica Verdoia, Saman Rasoul, Houng Bang Liew, Jawed Polad, Wan A. Ahmad, Robaayah Zambahari, Sonja Postma, Elvin Kedhi, Harry Suryapranata

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E990-E998
Number of pages27
JournalEurointervention
Volume15
Issue number11
DOIs
Publication statusPublished - Dec 2019

Keywords

  • ACS/NSTE-ACS
  • drug-eluting stent
  • STEMI
  • BARE-METAL STENTS
  • PRIMARY ANGIOPLASTY
  • ELUTING STENTS
  • METAANALYSIS
  • CLOPIDOGREL
  • TICAGRELOR
  • DURATION
  • SAFETY

Cite this

De Luca, G., Damen, S. A., Camaro, C., Benit, E., Verdoia, M., Rasoul, S., Liew, H. B., Polad, J., Ahmad, W. A., Zambahari, R., Postma, S., Kedhi, E., & Suryapranata, H. (2019). Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial). Eurointervention, 15(11), E990-E998. https://doi.org/10.4244/EIJ-D-19-00539